BridgeMD
New treatment option for Generalized Anxiety Disorder
Official title Navigated cTBS for the Treatment of Generalized Anxiety Disorder
ClinicalTrials.gov ID: NCT07121712
What this study is testing
- What it's testing
- The purpose of this study is to investigate the effectiveness of a non-invasive brain stimulation technique called continuous Theta Burst Stimulation (cTBS) for treating Generalized Anxiety Disorder (GAD). The researchers will use a neuronavigation system, which acts like a GPS for the brain based on a participant's own MRI scan, to guide the stimulation to a specific target in the brain's auditory association cortex.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Diagnosis of Generalized Anxiety Disorder (GAD) according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5)...
- Hamilton Anxiety Rating Scale (HAMA) score \> 14.
- Age between 18 and 60 years.
- More than 5 years of education.
- Right-handed.
You likely can't join if
- Presence of other psychiatric disorders, such as substance abuse, schizophrenia, schizoaffective disorder, hysteria, or autism.
- Presence of severe neurological diseases (e.g., stroke), or any personal or family history of epilepsy or seizures.
- Presence of severe somatic diseases, such as severe heart, liver, or renal insufficiency.
- Pregnant or lactating women.
- Contraindications to Transcranial Magnetic Stimulation (TMS) or Magnetic Resonance Imaging (MRI), such as the presence of a cardiac pacemaker...
- Inability to cooperate with experimental procedures due to conditions such as depressive stupor or severe claustrophobia.
See the full eligibility criteria
- Diagnosis of Generalized Anxiety Disorder (GAD) according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5), confirmed by at least two psychiatrists.
- Hamilton Anxiety Rating Scale (HAMA) score \> 14.
- Age between 18 and 60 years.
- More than 5 years of education.
- Right-handed.
- Normal or corrected-to-normal visual acuity.
- Able to cooperate with the completion of all experimental procedures.
- Willing and able to provide written informed consent.
- Presence of other psychiatric disorders, such as substance abuse, schizophrenia, schizoaffective disorder, hysteria, or autism.
- Presence of severe neurological diseases (e.g., stroke), or any personal or family history of epilepsy or seizures.
- Presence of severe somatic diseases, such as severe heart, liver, or renal insufficiency.
- Pregnant or lactating women.
- Contraindications to Transcranial Magnetic Stimulation (TMS) or Magnetic Resonance Imaging (MRI), such as the presence of a cardiac pacemaker, cochlear implant, cerebrovascular metal stent, or metal dentures.
- Inability to cooperate with experimental procedures due to conditions such as depressive stupor or severe claustrophobia.
The study team makes the final eligibility decision.
Where it's taking place
- Hefei, Anhui, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hefei, Anhui, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.